Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL555103 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL10953007 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL477953 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL18186951 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL10772647 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL18187342 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL2846645 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL18187344 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL18187333 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL2850911 | 1.00 | TSHR (0.69) | TSHRALDH1A1ABCC4MAPTTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781306-B2 | Mortar formulation comprising long chain acrylic ester modified vinyl ester polymers | DAIREN CHEMICAL CORPORATION (TW) | 2020-09-22 | — | — | US | disclosed |
| US-20190248998-A1 | LONG CHAIN ACRYLIC ESTER MODIFIED VINYL ESTER POLYMERS | DAIREN CHEMICAL CORPORATION (TW) | 2019-08-15 | — | — | US | disclosed |
| US-8816094-B2 | Hydrothiolation of unactivated alkenes | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2014-08-26 | — | — | US | disclosed |
| US-20130190505-A1 | Hydrothiolation of Unactivated Alkenes | Trustees of Dartmouth Office (US) | 2013-07-25 | — | — | US | disclosed |
| US-6451937-B1 | BY THERMALLY REACTING A FUNCTIONALIZING REAGENT AND THE HYDROCARBON IN THE PRESENCE OF A TRANSITION METAL COORDINATION CATALYST | SHELL OIL COMPANY | 2002-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190505-A1 | Hydrothiolation of Unactivated Alkenes | SLC6A6, TST, AGPAT5 | TSHR 1976/4885ALDH1A1 547/4885ABCC4 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.